Skip to main content

Voyager Therapeutics, Inc.

VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001640266

No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Voyager Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
127
−5 vs. Q1 2024
Shares held
38.1M
+2.57M (+7.2%) vs. Q1 2024
Total value
$301.6M
−$29.5M (−8.9%) vs. Q1 2024
New holders
23
43 more added
Sold out
28
40 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VYGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 127 institutions
Q1 2021: 101 institutionsQ2 2021: 78 institutionsQ3 2021: 69 institutionsQ4 2021: 59 institutionsQ1 2022: 70 institutionsQ2 2022: 78 institutionsQ3 2022: 69 institutionsQ4 2022: 70 institutionsQ1 2023: 82 institutionsQ2 2023: 106 institutionsQ3 2023: 111 institutionsQ4 2023: 107 institutionsQ1 2024: 132 institutionsQ2 2024: 127 institutionsQ3 2024: 128 institutionsQ4 2024: 133 institutionsQ1 2025: 116 institutionsQ2 2025: 113 institutionsQ3 2025: 117 institutionsQ4 2025: 125 institutionsQ1 2026: 135 institutionsQ2 2026: 135 institutions
Value heldQ2 2024: $301.6M
Q1 2021: $125.7MQ2 2021: $96.8MQ3 2021: $58.6MQ4 2021: $51.3MQ1 2022: $171.3MQ2 2022: $142.3MQ3 2022: $142.9MQ4 2022: $146.2MQ1 2023: $183.8MQ2 2023: $307.7MQ3 2023: $211.2MQ4 2023: $227.5MQ1 2024: $331.1MQ2 2024: $301.6MQ3 2024: $205.9MQ4 2024: $196.2MQ1 2025: $117.4MQ2 2025: $103.1MQ3 2025: $141.1MQ4 2025: $132.6MQ1 2026: $129.4MQ2 2026: $122.7M
Institutions holding VYGR and their total value by quarter
QuarterHoldersValue
Q2 2026135$122.7M
Q1 2026135$129.4M
Q4 2025125$132.6M
Q3 2025117$141.1M
Q2 2025113$103.1M
Q1 2025116$117.4M
Q4 2024133$196.2M
Q3 2024128$205.9M
Q2 2024127$301.6M
Q1 2024132$331.1M
Q4 2023107$227.5M
Q3 2023111$211.2M
Q2 2023106$307.7M
Q1 202382$183.8M
Q4 202270$146.2M
Q3 202269$142.9M
Q2 202278$142.3M
Q1 202270$171.3M
Q4 202159$51.3M
Q3 202169$58.6M
Q2 202178$96.8M
Q1 2021101$125.7M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Voyager Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding VYGR in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
D. E. Shaw & Co., Inc.205,601$1.63M0.00%−28,388−12.1%Reduced
Kestra Advisory Services, LLC241,519$1.91M0.01%−14,930−5.8%Reduced
Wellington Management Group LLP246,992$1.95M0.00%+42,963+21.1%Added
Fiduciary Trust Co259,397$2.05M0.03%00.0%Unchanged
JPMorgan Chase & Co275,443$2.18M0.00%−41,212−13.0%Reduced
Globeflex Capital L P291,293$2.30M0.24%−18,215−5.9%Reduced
Bank of New York Mellon Corp294,420$2.33M0.00%+44,289+17.7%Added
Woodline Partners LP300,000$2.37M0.02%00.0%Unchanged
Northern Trust Corp374,161$2.96M0.00%−15,655−4.0%Reduced
Goldman Sachs Group Inc443,984$3.51M0.00%+62,275+16.3%Added
Morgan Stanley496,969$3.93M0.00%+214,809+76.1%Added
AQR Capital Management LLC502,375$3.97M0.01%−291,259−36.7%Reduced
Federated Hermes, Inc.554,214$4.38M0.01%+2,638+0.5%Added
Vestal Point Capital, LP600,000$4.75M0.35%00.0%Unchanged
Bank of America Corp648,760$5.13M0.00%+294,317+83.0%Added
Dimensional Fund Advisors LP813,680$6.44M0.00%−291,875−26.4%Reduced
Price T Rowe Associates Inc989,549$7.83M0.00%−52,381−5.0%Reduced
American Century Companies Inc1,019,332$8.06M0.00%+249,659+32.4%Added
Erste Asset Management GmbH1,058,378$8.36M0.11%00.0%Unchanged
Geode Capital Management, LLC1,072,769$8.49M0.00%+100,405+10.3%Added
Great Point Partners LLC1,601,527$12.7M2.43%+1,601,527New
State Street Corp1,789,189$14.2M0.00%+40,021+2.3%Added
Farallon Capital Management, L.L.C.2,292,000$18.1M0.11%00.0%Unchanged
Vanguard Group Inc3,038,564$24.0M0.00%−193,134−6.0%Reduced
EcoR1 Capital, LLC3,917,546$31.0M0.95%00.0%Unchanged
Armistice Capital, LLC5,200,000$41.1M1.08%+528,000+11.3%Added
BlackRock Inc.5,312,617$42.0M0.00%+915,173+20.8%Added
Millennium Management LLC0$00.00%−100,725−100.0%Sold out
AXA S.A.0$00.00%−99,000−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−94,448−100.0%Sold out
Aviva PLC0$00.00%−70,285−100.0%Sold out
Alpha DNA Investment Management LLC0$00.00%−57,588−100.0%Sold out
Blackstone Group Inc.0$00.00%−50,848−100.0%Sold out
Marshall Wace, LLP0$00.00%−47,808−100.0%Sold out
Deerfield Management Company, L.P. (Series C)0$00.00%−32,005−100.0%Sold out
State of Wyoming0$00.00%−30,948−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−28,896−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−24,673−100.0%Sold out
XTX Topco Ltd0$00.00%−24,029−100.0%Sold out
Two Sigma Investments, LP0$00.00%−22,112−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−21,341−100.0%Sold out
Arrowstreet Capital, Limited Partnership0$00.00%−20,320−100.0%Sold out
American International Group, Inc.0$00.00%−19,397−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−17,500−100.0%Sold out
Jump Financial, LLC0$00.00%−16,168−100.0%Sold out
Bailard, Inc.0$00.00%−13,700−100.0%Sold out
ProShare Advisors LLC0$00.00%−10,876−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−10,039−100.0%Sold out
Fernwood Investment Management, LLC0$00.00%−7,593−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−7,413−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−1,743−100.0%Sold out
Quantbot Technologies LP0$00.00%−1,500−100.0%Sold out
Macroview Investment Management LLC0$00.00%−858−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−43−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−6−100.0%Sold out